Neutral impactStocks

Caplin Point slides 13% in 3 sessions after US FDA flags plant for action

Business Standard 26 min ago·18 Nov 2026, 6:31 am

US FDA classified the Gummidipoondi facility as OAI, indicating that the FDA believes the inspection findings warrant regulatory action

Key takeaways

  • Category: Stocks.

Why it matters

A routine update. Use the price and stock snapshot to gauge how the market is responding.

Summary & analysis by DocStoX. Full story at Business Standard.

More Stocks news

More news

Latest headlines

More news

Aggregated from third-party sources for research. Sentiment & impact are AI-generated, indicative, not advice.